Add to Calendar 8/26/2020 8:00:00 AM 8/27/2020 5:00:00 PM 2020 State of Possible Conference

Special thanks to our Platinum Sponsor Morgan Stanley

Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from registrations@bizzabo.com.


The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.  

We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.

"It's the Woodstock of Life Sciences, with all-star performers playing their greatest hits all on one stage.” – 2019 State of Possible Conference attendee
 
If you haven’t attended our State of Possible Conference before, it is the premier east coast life sciences conference. We have some of the brightest names in biotech talking about the issues impacting our industry, covering topics from the realities of precision medicine to advancing new drug targets faster.

To inquire about sponsorship opportunities, contact Laura Rudberg.

2020 State of Possible Conference Refund Policy

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Online Conference, Link will be sent in advance of the event.
Founder & CSO, Nuritas
Dr. Nora Khaldi is the Founder and Chief Scientific Officer of Nuritas, a company helping to solve some of the greatest challenges in biology and medicine. She has a PhD in Molecular Evolution and Bioinformatics as well as a Master’s in Mathematics. Dr. Khaldi is disrupting the status quo of drug discovery by integrating artificial intelligence (AI) and big data to extract peptides from natural sources for the development of therapies to address a broad range of health areas. She has a unique interdisciplinary background in Mathematics, Bioinformatics and Molecular Biology. Nora was the first scientist to show gene transfer between multi-cellular species. This ground-breaking find put into question many of the phylogenetic methods currently in use today. Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine. Starting from an idea at her kitchen table and initially funded by personal savings, Dr Khaldi has grown Nuritas rapidly surrounding herself with a team of experts and raising funding from numerous sources in excess of $65m. She also spearheaded the expansion of Nuritas to the USA with the opening of a Boston office. Dr Khaldi has been recognised with numerous awards for her innovation and entrepreneurship. Of note, she was named Woman of the Decade in Business and Leadership at the Women Economic Forum (WEF) European Union Event and received the Rising Star prize form the Tech Excellence Awards in 2017. In 2019 she was inducted into the Young Global Leaders, the World Economic Forum’s foundation for remarkable leaders under 40. Dr. Khaldi continues to lead the Nuritas team in their goal of reaching billions of people with their life-changing ingredients, working with global leaders such as Nestle and BASF to achieve this.

Brought to you by